13 results
Keyword RoActemra Remove keyword
Type of content
News Remove News filter
-
List item
News: ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2
Last updated: 09/12/2022statement does not refer to RoActemra, another monoclonal antibody … -
List item
News: EMA adopts first list of critical medicines for COVID-19
Last updated: 08/06/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022
PRAC, Last updated: 08/04/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 March 2022
PRAC, Last updated: 11/03/202213 4.2.2. Tocilizumab - ROACTEMRA (CAP … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7 - 10 February 2022
PRAC, Last updated: 11/02/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022
PRAC, Last updated: 14/01/2022 -
List item
News: Emer Cooke’s end-of-year message
Last updated: 22/12/2021Article 5(3) 6 Dec 2021 RoActemra new COVID-19 indication 5 … casirivimab / imdevimab) • RoActemra (tocilizumab) • Xevudy … -
List item
News: EMA recommends approval for use of RoActemra in adults with severe COVID-19
CHMP, Last updated: 06/12/2021recommends approval for use of RoActemra in adults with severe COVID-1 … recommends approval for use of RoActemra in adults with severe COVID-1 … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021
PRAC, Last updated: 03/12/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021
PRAC, Last updated: 29/10/20214.1.4. Tocilizumab – ROACTEMRA (CAP … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021
PRAC, Last updated: 01/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/20214.1.6. Tocilizumab – ROACTEMRA (CAP … -
List item
News: EMA starts evaluating use of RoActemra in hospitalised adults with severe COVID-19
CHMP, Last updated: 16/08/2021EMA starts evaluating use of RoActemra in hospitalised adults with … EMA starts evaluating use of RoActemra in hospitalised adults with …